A. The Food and Drug Administration has approved montelukast to treat asthma, exercise-induced bronchoconstriction (trouble ...

MORE: Patients, health care providers face shortages of critical drugs, Senate report finds "All drug classes are vulnerable to shortage," Dr. Paul Abramowitz, CEO of ASHP, said in a statement.

Dermatology overtook anti-inflammatory as the largest specialty drug class by spend in 2024, rising to 27% of total specialty plan spend – up from 24.1% in 2023.

TG Therapeutics is pausing its cancer drug research and withdrawing the approved cancer drug Ukoniq from the market. The move comes as the FDA places greater scrutiny on Ukoniq’s drug class ...

Image source: Getty Images. Oncology Although oncology may not be the fastest-growing indication of them all, spending on cancer drugs in 2021 is expected to eclipse all other drug classes.

Previous analyses of new drug approvals have suggested that phenotypic screening strategies have been more productive than target-based approaches in the discovery of first-in-class small-molecule ...

Move over, hepatitis C. These are the fastest-growing drug classes However, according to the latest QuintilesIMS Institute report , Outlook for Global Medicines Through 2021: Balancing Cost and ...

Specialty drug costs as a whole rose by 25% in 2014 according to the nation's largest pharmacy-benefit manager. The following specialty therapy classes appear to be the primary culprits behind ...

BCG analyzed three variables – timing of market entry, therapeutic advantage, and commercial success – for drugs in the same mechanistic class launched from 1990 – 2010.

3 Drug Classes That May Become Obsolete Within 3 Years By Sean Williams – Sep 13, 2013 at 7:00PM ...